Product Overview: Strattera 10 Eli Lilly
Strattera 10 by Eli Lilly is an atomoxetine hydrochloride formulation representing a selective norepinephrine reuptake inhibitor (SNRI) compound developed for pharmaceutical research. As a non-stimulant medication originally investigated for attention deficit hyperactivity disorder, atomoxetine provides researchers with a valuable tool for studying noradrenergic neurotransmission pathways. The compound selectively inhibits the presynaptic norepinephrine transporter, leading to increased extracellular concentrations of norepinephrine in prefrontal cortex regions. This mechanism makes it particularly valuable for investigators examining cognitive function, executive control, and attention-related neural circuits. Research institutions studying neuropharmacology can examine atomoxetine’s effects on catecholamine metabolism and its interaction with dopaminergic systems. The Eli Lilly formulation ensures pharmaceutical-grade quality for precise experimental protocols.
Laboratory Applications
Researchers investigating neurochemical pathways utilise atomoxetine in studies examining selective norepinephrine reuptake inhibition mechanisms. The compound demonstrates unique pharmacological properties compared to stimulant medications, making it valuable for comparative neuropharmacology studies. Scientists can evaluate its effects on prefrontal cortex function and working memory systems in controlled laboratory environments. Stroid UK Shop employ atomoxetine to study attention networks and cognitive enhancement mechanisms. Investigators examining atomoxetine formulations can compare its selectivity profile against other neurotransmitter modulators. The compound’s minimal affinity for dopamine transporters allows researchers to isolate noradrenergic effects from dopaminergic influences. Studies can examine its potential neuroprotective properties and effects on neural plasticity. Researchers investigating selective modulators often include atomoxetine as a reference compound. Comparative studies with bioactive peptides help elucidate different mechanisms of cognitive enhancement.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Atomoxetine Hydrochloride |
| Strength | 10mg per unit |
| Manufacturer | Eli Lilly |
| CAS Number | 82248-59-7 |
| Molecular Formula | C₁₇H₂₁NO·HCl |
| Storage | Room temperature, dry conditions |
Research Compliance
This atomoxetine hydrochloride product is supplied exclusively for in-vitro laboratory research purposes. Not approved for human consumption, therapeutic use, or clinical applications. Researchers must ensure appropriate laboratory protocols and safety measures when handling this compound. This product is intended solely for qualified research institutions and licensed laboratories conducting legitimate scientific studies on neurotransmitter systems and pharmacological mechanisms.
